GLOBAL EQUITY MARKETS – July 22, 2017
REVIEW
U.S. Biotech stocks resume uptrend after their strong breakout in the last week of June. June 17, 2017 and June 24, 2017 Global Equity Markets reports drew attention to the strength in the Biotech ETFs and alerted members on the multi-month bullish chart pattern completions. Both SPDR S&P BIOTECH ETF and ISHARES NASDAQ BIOTECH ETF had strong breakouts. After few weeks of pull back to the previously broken chart pattern boundary, NASDAQ BIOTECH INDEX resumed its uptrend. Read More
GLOBAL EQUITY MARKETS – July 15, 2017
REVIEW
Global equities had a strong performance led by Emerging Market equities and mainly Chinese Large-caps. MSCI Emerging Markets Index breached its decade-long trend line resistance at 1,020 levels. Tech Charts Global Equity Markets reports drew attention to the developing strength in Emerging Asia equities. Following the strong performance of S.Korea, Taiwan, India and Philippines, Chinese equities are also joining the list. An interim update was sent out during the week discussing the strong breakout on the Ishares China Large Cap ETF (FXI). Below charts feature the MSCI Emerging Markets Index (Price index in USD) and the New York Stock Exchange listed iShares MSCI Emerging Markets ETF (EEM).
INTERIM UPDATE – July 13, 2017
ISHARES CHINA LARGE CAP ETF (FXI)
A major chart pattern development is taking place on the Chinese equity ETF that is listed on the New York Stock Exchange. Ishares China Large Cap ETF is possibly completing a major 20 month-long base formation. Multi-month H&S bottom chart pattern has a neckline at 39.65 levels. Breakout attempt in the first quarter of 2017, was followed by a short-term set-back that found support at the neckline. However, during this week we can see that the China Large Cap ETF gained momentum once again. Read More
